Results

Viridian Therapeutics Inc.

11/15/2021 | Press release | Distributed by Public on 11/15/2021 06:06

Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)